T1	p 262 297	individuals > or =60 years of age .
T2	p 476 548	subjects > or =50 years of age . Subjects with a negative history for HZ
T3	o 902 991	VZV antibody geometric mean titer ( GMT ; day 28 ) , the VZV antibody geometric mean rise
T4	o 1025 1089	incidence of vaccine-related serious adverse experiences ( AEs )